(-)-CP 55,940 (10 mg/mL in methanol)

CAS : 83002-04-4

Ref. TR-C781410

Informations sur le produit

• Nom: (-)-CP 55,940 (10 mg/mL in methanol)
• Synonymes: 2-[(1S,2S,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol, (-)-Cp 55940, 2-[(1S,2R,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol, 5-(1,1-Dimethylheptyl)-2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol, 5-(1,1-dimethylheptyl)-2-[(1S,2R,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol, Phenol, 5-(1,1-dimethylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-, (1α,2β,5α)-(-)-, phenol, 5-(1,1-dimethylheptyl)-2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-, phenol, 5-(1,1-dimethylheptyl)-2-[(1S,2R,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-

Description

Applications CP 55,940 is a cannabinoid agonist which is considerably more potent than Δ9-THC in both behavioral tests and receptor binding assays. Displays high and roughly equal affinity for both central and peripheral cannabinoid receptors (Ki = 0.6 - 5.0 and 0.7 - 2.6 nM at CB1 and CB2 respectively; EC50 values are 0.2, 0.3 and 5 nM at CB1, CB2 and GRP55 respectively).Controlled substance. Synthetic Cannabinoids
References Wiley, et al.: Neuropharmacology, 34, 669 (1995); Griffin, et al.: J. Pharmacol. Exp. Ther., 285, 553 (1998); Thomas, et al.: J. Pharmacol. Exp. Ther., 285, 285 (1998); Ryberg, et al.: Br. J. Pharmacol., 152, 1092 (2007);

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 376.57
• Formule: C₂₄H₄₀O₃
• Couleur/Forme: Single Solution
• InChI: InChI=1S/C24H40O3/c1-4-5-6-7-14-24(2,3)19-11-13-21(23(27)16-19)22-17-20(26)12-10-18(22)9-8-15-25/h11,13,16,18,20,22,25-27H,4-10,12,14-15,17H2,1-3H3/t18-,20-,22-/m0/s1
• Code InChI: InChIKey=YNZFFALZMRAPHQ-KXBOQVSUSA-N
• SMILES: CCCCCCC(C)(C)c1ccc([C@@H]2C[C@H](O)CCC2CCCO)c(O)c1